InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Chopas James George, VP/Chief Accounting Officer. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 10 filings have been published. The latest transaction was disclosed on 21 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
65,955 shares
Common Stock
SEC:0001193125-26-224627·
65,955 shares
Common Stock
SEC:0001193125-26-224627:0·
010,657 shares0
Common Stock
SEC:0000899243-22-005090·
010,657 shares0
Common Stock
SEC:0000899243-22-005090:0·
06,974 shares0
Common Stock
SEC:0001127602-22-002056·
06,974 shares0
Common Stock
SEC:0001127602-22-002056:0·
0882 shares0
Common Stock
SEC:0001127602-21-027699·
0882 shares0
Common Stock
SEC:0001127602-21-027699:0·
07,600 shares0
Common Stock
SEC:0000899243-21-034732·
07,600 shares0
Common Stock
SEC:0000899243-21-034732:0·
10 of 10 declarations
About Chopas James George
James George Chopas is the Vice President and Chief Accounting Officer at Apellis Pharmaceuticals, Inc. In this role, he is responsible for managing the company's finances and accounting. His expertise in accounting is essential to ensuring financial compliance and transparency in operations.
